Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 | P21453 | 1/20 | 0.79 |
| ▸ | ENPP2 | Q13822 | 8/20 | 0.77 |
| ▸ | LPAR3 | Q9UBY5 | 7/20 | 0.77 |
| ▸ | LPAR1 | Q92633 | 6/20 | 0.77 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.77 |
| ▸ | MAPT | P10636 | 1/20 | 0.69 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.69 |
| ▸ | PRKCA | P17252 | 2/20 | 0.68 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.68 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.68 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.68 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.59 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.59 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.59 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22798379 | 1.00 | S1PR1 (0.79) | S1PR1ENPP2LPAR3LPAR1SMN1; SMN2 | |
| SCHEMBL27892952 | 1.00 | S1PR1 (0.79) | S1PR1ENPP2LPAR3LPAR1SMN1; SMN2 | |
| SCHEMBL22798380 | 1.00 | S1PR1 (0.79) | S1PR1ENPP2LPAR3LPAR1SMN1; SMN2 | |
| SCHEMBL18932079 | 1.00 | S1PR1 (0.79) | S1PR1ENPP2LPAR3LPAR1SMN1; SMN2 | |
| SCHEMBL22798411 | 1.00 | S1PR1 (0.79) | S1PR1ENPP2LPAR3LPAR1SMN1; SMN2 | |
| SCHEMBL22798172 | 1.00 | S1PR1 (0.79) | S1PR1ENPP2LPAR3LPAR1SMN1; SMN2 | |
| SCHEMBL22798410 | 1.00 | S1PR1 (0.79) | S1PR1ENPP2LPAR3LPAR1SMN1; SMN2 | |
| Alcohol SCHEMBL28119149 | 0.99 | S1PR1 (0.77) | S1PR1ENPP2LPAR3LPAR1SMN1; SMN2 | |
| Monoethanolamine SCHEMBL28004764 | 0.93 | S1PR1 (0.71) | S1PR1ENPP2LPAR3LPAR1SMN1; SMN2 | |
| SCHEMBL22797755 | 0.92 | S1PR1 (0.93) | S1PR1ENPP2LPAR3LPAR1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250037787-A1 | CONCENTRATION BOUNDS IN LARGE NETWORKS | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2025-01-30 | — | — | US | disclosed |
| US-20220107322-A1 | LIPID, PROTEIN, AND METABOLITE MARKERS FOR THE DIAGNOSIS AND TREATMENT OF PROSTATE CANCER | BPGBIO, INC. | 2022-04-07 | — | — | US | disclosed |
| EP-3753020-A1 | CONCENTRATION BOUNDS IN LARGE NETWORKS | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2020-12-23 | — | — | EP | disclosed |
| US-9393328-B2 | Sonochemical induction of ABCA1 expression and compositions therefor | SONOGENE LLC (US) | 2016-07-19 | — | — | US | disclosed |
| US-20150343098-A1 | SONOCHEMICAL INDUCTION OF ABCA1 EXPRESSION AND COMPOSITIONS THEREFOR | SONOGENE LLC (US) | 2015-12-03 | — | — | US | disclosed |
| US-9101745-B2 | Sonochemical induction of ABCA1 expression and compositions therefor | SONOGENE LLC (US) | 2015-08-11 | — | — | US | disclosed |
| US-20140276363-A1 | Sonochemical Induction of ABCA1 Expression and Compositions Therefor | SONOTHERA, INC. | 2014-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140276363-A1 | Sonochemical Induction of ABCA1 Expression and Compositions Therefor | SREBF1, SREBF2, AUP1 | S1PR1 2148/4885ENPP2 3096/4885LPAR3 2190/4885 |
| US-20150343098-A1 | SONOCHEMICAL INDUCTION OF ABCA1 EXPRESSION AND COMPOSITIONS THEREFOR | SREBF1, SREBF2, AUP1 | S1PR1 2124/4885ENPP2 2921/4885LPAR3 2661/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.